Herring Bradley

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 90% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Herring Bradley's trades of Enfusion Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
399.41
Quantity 48,001 +35.6%
Value US$4,669,649
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
263.01
Quantity 12,142
Value US$4,873,033
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
279.33
Quantity 86,300 -37.6%
Value US$2,615,479
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
11.48
Quantity 1,533
Value US$17,601
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
10.13
Quantity 4,134 -1.5%
Value US$41,877
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
10.13
Quantity 4,134
Value US$41,879
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
10.61
Quantity 24,443 -8.3%
Value US$259,340
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
10.61
Quantity 24,443
Value US$259,416
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
8.95
Quantity 2,090 -1.0%
Value US$18,706
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
8.95
Quantity 2,090
Value US$18,706
US Enfusion Inc (ENFN)
Transaction date
Sale
Price
9.23
Quantity 1,998 -0.9%
Value US$18,442
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
9.23
Quantity 1,998
Value US$18,447
US Enfusion Inc (ENFN)
Transaction date
Proposed sale
Price
9.23
Quantity 1,998
Value US$18,447
Transaction date
Planned sale
Price
89.30
Quantity 2,000 -6.5%
Value US$178,600
Transaction date
Planned sale
Price
93.16
Quantity 5,940 -16.1%
Value US$553,393
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-07 2025-03-05
US Enfusion Inc (ENFN)
S Sale
48,001 +35.6%
399.41
US$4,669,649 		48,001 +35.6% 399.41 US$4,669,649
2025-03-05 2025-03-05
US Enfusion Inc (ENFN)
PrS Proposed sale
12,142
263.01
US$4,873,033 		12,142 263.01 US$4,873,033
2025-03-05 2025-03-03
US Enfusion Inc (ENFN)
S Sale
86,300 -37.6%
279.33
US$2,615,479 		86,300 -37.6% 279.33 US$2,615,479
2025-03-03 2025-03-03
US Enfusion Inc (ENFN)
PrS Proposed sale
1,533
11.48
US$17,601 		1,533 11.48 US$17,601
2025-01-10 2025-01-07
US Enfusion Inc (ENFN)
S Sale
4,134 -1.5%
10.13
US$41,877 		4,134 -1.5% 10.13 US$41,877
2025-01-07 2025-01-07
US Enfusion Inc (ENFN)
PrS Proposed sale
4,134
10.13
US$41,879 		4,134 10.13 US$41,879
2024-12-26 2024-12-20
US Enfusion Inc (ENFN)
S Sale
24,443 -8.3%
10.61
US$259,340 		24,443 -8.3% 10.61 US$259,340
2024-12-20 2024-12-20
US Enfusion Inc (ENFN)
PrS Proposed sale
24,443
10.61
US$259,416 		24,443 10.61 US$259,416
2024-01-10 2024-01-09
US Enfusion Inc (ENFN)
S Sale
2,090 -1.0%
8.95
US$18,706 		2,090 -1.0% 8.95 US$18,706
2024-01-09 2024-01-09
US Enfusion Inc (ENFN)
PrS Proposed sale
2,090
8.95
US$18,706 		2,090 8.95 US$18,706
2024-01-10 2024-01-08
US Enfusion Inc (ENFN)
S Sale
1,998 -0.9%
9.23
US$18,442 		1,998 -0.9% 9.23 US$18,442
2024-01-09 2024-01-08
US Enfusion Inc (ENFN)
PrS Proposed sale
1,998
9.23
US$18,447 		1,998 9.23 US$18,447
2024-01-08 2024-01-08
US Enfusion Inc (ENFN)
PrS Proposed sale
1,998
9.23
US$18,447 		1,998 9.23 US$18,447
2021-08-11 2021-08-09
PlS Planned sale
2,000 -6.5%
89.30
US$178,600 		2,000 -6.5% 89.30 US$178,600
2021-06-14 2021-06-10
PlS Planned sale
5,940 -16.1%
93.16
US$553,393 		5,940 -16.1% 93.16 US$553,393